Literature DB >> 1394165

Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County.

L Bernstein1, R K Ross.   

Abstract

To determine whether non-Hodgkin's lymphoma (NHL) is related to prior medication use or health history, a population-based case-control study was conducted. A total of 619 male and female residents of Los Angeles County who were diagnosed with NHL between January 1, 1979, and June 30, 1982, were compared to individually age-, race-, and sex-matched neighborhood controls with regard to history of use of 49 different medications, 47 chronic and infectious diseases or other conditions, 15 types of immunizations, and 15 specific allergic reactions. Based on preliminary analyses, long-term regular use of aspirin and other pain relievers and greater than or equal to 2 mo of treatment with penicillin and other antibiotics were associated with significantly increased risk of NHL. Other drugs associated with greater risk of NHL were use of digitalis and estrogen replacement therapy by women, use of corticosteroids, and greater than or equal to 2 mo of use of tranquilizers. NHL was strongly associated with a prior history of cancer. Cases more frequently reported histories of kidney infections and anemia than did controls; a history of eczema appeared to be protective against NHL. Women who had been immunized against polio by injectable vaccine were at significantly lower risk of NHL than women who had not received this immunization. Among men, cholera immunization and allergy to nuts and berries were significantly protective. Subjects who had received a yellow fever immunization also had lower NHL risk. Further analyses of these data will attempt to establish the relative importance of these potential risk factors and to determine whether any are markers of early symptoms of NHL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394165

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment.

Authors:  Elizabeth A Platz; Srinivasan Yegnasubramanian; Jun O Liu; Curtis R Chong; Joong Sup Shim; Stacey A Kenfield; Meir J Stampfer; Walter C Willett; Edward Giovannucci; William G Nelson
Journal:  Cancer Discov       Date:  2011-06       Impact factor: 39.397

2.  Common immune-related exposures/conditions and risk of non-Hodgkin lymphoma: a case-control study of disease-discordant twin pairs.

Authors:  Jun Wang; Thomas M Mack; Ann S Hamilton; Amie E Hwang; Bharat N Nathwani; Kamil Masood; Laura H Buchanan; Leslie Bernstein; Dennis M Deapen; Otoniel Martínez-Maza; Wendy Cozen
Journal:  Am J Epidemiol       Date:  2015-08-12       Impact factor: 4.897

3.  Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).

Authors:  Sophia S Wang; Susan L Slager; Paul Brennan; Elizabeth A Holly; Silvia De Sanjose; Leslie Bernstein; Paolo Boffetta; James R Cerhan; Marc Maynadie; John J Spinelli; Brian C H Chiu; Pier Luigi Cocco; Fiona Mensah; Yawei Zhang; Alexandra Nieters; Luigino Dal Maso; Paige M Bracci; Adele Seniori Costantini; Paolo Vineis; Richard K Severson; Eve Roman; Wendy Cozen; Dennis Weisenburger; Scott Davis; Silvia Franceschi; Carlo La Vecchia; Lenka Foretova; Nikolaus Becker; Anthony Staines; Martine Vornanen; Tongzhang Zheng; Patricia Hartge
Journal:  Blood       Date:  2006-12-21       Impact factor: 22.113

4.  Occupation and malignant lymphoma: a population based case control study in Germany.

Authors:  B Mester; A Nieters; E Deeg; G Elsner; N Becker; A Seidler
Journal:  Occup Environ Med       Date:  2006-01       Impact factor: 4.402

5.  [Rationale for bone marrow examination in patients with inflammatory rheumatic diseases].

Authors:  Jutta G Richter; Pascal Gossen; Ulrich Germing; Sabine Blum; Barbara Hildebrandt; Stefan Braunstein; Dörte Huscher; Matthias Schneider
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

6.  Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition.

Authors:  Laura Costas; Leila Lujan-Barroso; Yolanda Benavente; Naomi E Allen; Pilar Amiano; Eva Ardanaz; Caroline Besson; Heiner Boeing; Bas Bueno-de-Mesquita; Iris Cervenka; Renée T Fortner; Agnès Fournier; Marc Gunter; Sophia Harlid; José María Huerta; Mats Jerkeman; Karin Jirström; Rudolf Kaaks; Anna Karakatsani; Kay-Tee Khaw; Anastasia Kotanidou; Eiliv Lund; Giovanna Masala; Amalia Mattiello; Beatrice Melin; Virginia Menéndez; Neil Murphy; Alexandra Nieters; Kim Overvad; Elio Riboli; Carlotta Sacerdote; Maria-Jose Sánchez; Julie A Schmidt; Sabina Sieri; Anne Tjønneland; Antonia Trichopoulou; Rosario Tumino; Roel Vermeulen; Elisabete Weiderpass; Silvia de Sanjosé; Antonio Agudo; Delphine Casabonne
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

7.  Common immune-related risk factors and incident non-Hodgkin lymphoma: the multiethnic cohort.

Authors:  Eva Erber; Unhee Lim; Gertraud Maskarinec; Laurence N Kolonel
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

8.  Postmenopausal hormone therapy and non-Hodgkin lymphoma: a pooled analysis of InterLymph case-control studies.

Authors:  E V Kane; L Bernstein; P M Bracci; J R Cerhan; L Costas; L Dal Maso; E A Holly; C La Vecchia; K Matsuo; S Sanjose; J J Spinelli; S S Wang; Y Zhang; T Zheng; E Roman; A Kricker
Journal:  Ann Oncol       Date:  2012-09-11       Impact factor: 32.976

9.  Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.

Authors:  Nilesh W Gaikwad; Li Yang; Dennis D Weisenburger; Julie Vose; Cheryl Beseler; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

10.  Reproductive factors and non-Hodgkin lymphoma risk in the California Teachers Study.

Authors:  Jennifer Prescott; Yani Lu; Ellen T Chang; Jane Sullivan-Halley; Katherine D Henderson; Christina A Clarke; Huiyan Ma; Claire Templeman; Dennis Deapen; Leslie Bernstein
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.